Berkshire Asset Management’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-15,000
| Closed | -$84K | – | 230 |
|
|
2022
Q1 | $84K | Hold |
15,000
| – | – | 0.01% | 200 |
|
|
2021
Q4 | $91K | Sell |
15,000
-5,000
| -25% | -$30.3K | 0.01% | 237 |
|
|
2021
Q3 | $195K | Hold |
20,000
| – | – | 0.01% | 233 |
|
|
2021
Q2 | $286K | Buy |
20,000
+5,000
| +33% | +$71.5K | 0.02% | 200 |
|
|
2021
Q1 | $356K | Hold |
15,000
| – | – | 0.03% | 173 |
|
|
2020
Q4 | $200K | Buy |
+15,000
| New | +$200K | 0.02% | 213 |
|